RxDoctor Payments Data

Syed M Khurram Owais, MD

Anesthesiology · Boston, MANPI 1083096358

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Boston Scientific at 39.5% of the total. Reporting peaked in 2019 at $3,471 and has fallen 83.5% since, to $574 in 2025. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,978in general payments, 2019–2025

Across 137 payments — averaging $72.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • SPR Therapeutics, Inc$2K
  • Abbott$2K
  • Medtronic$861
  • Nevro Corp.$790
  • Vertos Medical, Inc.$126
  • plus $394 from 11 others

What the payments were for

  • Travel & lodging$5,19252%
  • Food & beverage$4,74348%
  • Education$440%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,978 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$68,912
Medicare patients
230
Services billed
616

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin82$934
Pregabalin39$621
Lidocaine11$585
Tizanidine Hcl23$485
Methocarbamol27$449
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$230
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$202
Cyclobenzaprine Hcl14$163
Tramadol Hcl27$76

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →